X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15) 15
animals (9) 9
indoles - pharmacology (8) 8
mice (6) 6
oncology (6) 6
enzyme inhibitors - pharmacology (5) 5
multiple myeloma (5) 5
multiple myeloma - drug therapy (5) 5
article (4) 4
biochemistry & molecular biology (4) 4
index medicus (4) 4
multiple myeloma - immunology (4) 4
tumor cells, cultured (4) 4
angiogenesis (3) 3
apoptosis - drug effects (3) 3
cell division - drug effects (3) 3
cell line, tumor (3) 3
cells (3) 3
cyclin-dependent kinases - antagonists & inhibitors (3) 3
dose-response relationship, drug (3) 3
expression (3) 3
female (3) 3
flow cytometry (3) 3
imidazoles - pharmacology (3) 3
immunology (3) 3
killer cells, natural - immunology (3) 3
mice, scid (3) 3
receptors, immunologic - genetics (3) 3
research (3) 3
signaling lymphocytic activation molecule family (3) 3
xenograft model antitumor assays (3) 3
activation (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibodies, monoclonal, humanized - pharmacology (2) 2
antibody-dependent cell cytotoxicity (2) 2
antibody-dependent cell cytotoxicity - drug effects (2) 2
antitumor-activity (2) 2
binding sites (2) 2
biography (2) 2
biophysics (2) 2
cancer research (2) 2
carcinoma, squamous cell - pathology (2) 2
cell biology (2) 2
cell line (2) 2
cell movement - drug effects (2) 2
cracc (2) 2
cs1 (2) 2
cyclin-dependent kinase 2 (2) 2
cytotoxicity (2) 2
elotuzumab (2) 2
gene expression profiling (2) 2
genetics (2) 2
genetics & heredity (2) 2
glutathione transferase - metabolism (2) 2
hemic and lymphatic diseases (2) 2
immune system diseases (2) 2
in-vitro (2) 2
in-vivo (2) 2
killer cells (2) 2
killer cells, natural - drug effects (2) 2
killer cells, natural - metabolism (2) 2
kinase (2) 2
kinetics (2) 2
lenalidomide (2) 2
lymphocyte activation (2) 2
magnetic resonance spectroscopy (2) 2
medicine & public health (2) 2
model (2) 2
monoclonal antibodies (2) 2
multiple myeloma - metabolism (2) 2
multiple myeloma - pathology (2) 2
multiple-myeloma (2) 2
natural killer cells (2) 2
pharmacology & pharmacy (2) 2
phosphorylation (2) 2
phosphorylation - drug effects (2) 2
protein (2) 2
protein binding (2) 2
protein-serine-threonine kinases - antagonists & inhibitors (2) 2
proteins - metabolism (2) 2
receptors, immunologic - immunology (2) 2
receptors, immunologic - metabolism (2) 2
risk factors (2) 2
slamf7 (2) 2
32.01/.08 (1) 1
327.01 (1) 1
3t3 cells (1) 1
4-kringle antagonist (1) 1
791.43.03 (1) 1
adaptor proteins, signal transducing (1) 1
adenine deaminase (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - metabolism (1) 1
adenocarcinoma - pathology (1) 1
adenosine triphosphate - antagonists & inhibitors (1) 1
adenosine triphosphate - metabolism (1) 1
adenosine triphosphate - pharmacology (1) 1
adult (1) 1
aged (1) 1
amino acid sequence (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 05/2008, Volume 14, Issue 9, pp. 2775 - 2784
Journal Article
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 12/2013, Volume 62, Issue 12, pp. 1841 - 1849
Journal Article
Journal Article
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 01/2015, Volume 64, Issue 1, p. 61
  Elotuzumab is a humanized monoclonal antibody specific for signaling lymphocytic activation molecule-F7 (SLAMF7, also known as CS1, CD319, or CRACC) that... 
Monoclonal antibodies | Killer cells | Interleukins | Tumor necrosis factor | Multiple myeloma
Journal Article
Oncogene, ISSN 0950-9232, 01/2004, Volume 23, Issue 4, pp. 873 - 882
Journal Article
Journal Article
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2006, Volume 103, Issue 44, pp. 16153 - 16158
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 1988, Volume 167, Issue 5, pp. 1608 - 1615
Journal Article
Blood, ISSN 0006-4971, 11/2006, Volume 108, Issue 11, pp. 3503 - 3503
Abstract Introduction: We have recently shown that CS1 (CD2 subset 1, CRACC, SLAMF7), a cell surface glycoprotein of the CD2 family, is uniformly expressed on... 
Journal Article